BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Madni A, Batool A, Noreen S, Maqbool I, Rehman F, Kashif PM, Tahir N, Raza A. Novel nanoparticulate systems for lung cancer therapy: an updated review. J Drug Target 2017;25:499-512. [PMID: 28151021 DOI: 10.1080/1061186X.2017.1289540] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives. Int J Nanomedicine 2021;16:1313-30. [PMID: 33628022 DOI: 10.2147/IJN.S289443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
2 Majumder J, Minko T. Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations. Pharmaceutics 2021;13:1063. [PMID: 34371754 DOI: 10.3390/pharmaceutics13071063] [Reference Citation Analysis]
3 Prakashkumar N, Asik RM, Kavitha T, Archunan G, Suganthy N. Unveiling the Anticancer and Antibiofilm Potential of Catechin Overlaid Reduced Graphene Oxide/Zinc Oxide Nanocomposites. J Clust Sci. [DOI: 10.1007/s10876-021-02194-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Han R, Guan Y, Li M, Xu A, Wu D, Li P, Wang E, Sun P, Fei G, Zhou S, Wang R, Wu YS. Efficacy and Safety of Nanoadministration in the Treatment of Non-Small-Cell Lung Cancer Is Good to Some Extent: A Systematic Review and Meta-Analysis. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/9017198] [Reference Citation Analysis]
5 Tan S, Wang G. Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo. Drug Des Devel Ther 2017;11:3519-29. [PMID: 29263650 DOI: 10.2147/DDDT.S151422] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
6 Anderson CF, Grimmett ME, Domalewski CJ, Cui H. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1586. [PMID: 31602823 DOI: 10.1002/wnan.1586] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
7 Riyaz B, Sudhakar K, Mishra V. Quantum Dot-Based Drug Delivery for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Elsevier; 2019. pp. 311-26. [DOI: 10.1016/b978-0-12-815720-6.00013-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Guo F, Wu J, Wu W, Huang D, Yan Q, Yang Q, Gao Y, Yang G. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors. J Nanobiotechnology 2018;16:57. [PMID: 30012166 DOI: 10.1186/s12951-018-0384-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
9 Tang X, Wang Z, Wei F, Mu W, Han X. Recent Progress of Lung Cancer Diagnosis Using Nanomaterials. Crystals 2021;11:24. [DOI: 10.3390/cryst11010024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Noreen S, Ma JX, Saeed M, Pervaiz F, Hanif MF, Ahmed B, Farooq MI, Akram F, Safdar M, Madni A, Naveed M, Chang-Xing L. Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis. Drug Deliv Transl Res 2022. [PMID: 35499715 DOI: 10.1007/s13346-022-01152-3] [Reference Citation Analysis]
11 Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Noreen S, Murtaza G. Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature. Int J Nanomedicine 2021;16:7517-33. [PMID: 34795481 DOI: 10.2147/IJN.S333657] [Reference Citation Analysis]
12 He Y, Xiong T, He S, Sun H, Huang C, Ren X, Wu L, Patterson LH, Zhang J. Pulmonary Targeting Crosslinked Cyclodextrin Metal–Organic Frameworks for Lung Cancer Therapy. Adv Funct Mater 2021;31:2004550. [DOI: 10.1002/adfm.202004550] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
13 Guo F, Fu Q, Jin C, Ji X, Yan Q, Yang Q, Wu D, Gao Y, Hong W, Li A, Yang G. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment. Drug Deliv 2019;26:1027-38. [PMID: 31691601 DOI: 10.1080/10717544.2019.1676843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Montané X, Bajek A, Roszkowski K, Montornés JM, Giamberini M, Roszkowski S, Kowalczyk O, Garcia-Valls R, Tylkowski B. Encapsulation for Cancer Therapy. Molecules 2020;25:E1605. [PMID: 32244513 DOI: 10.3390/molecules25071605] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
15 Wang J, Li T, Yue C, Zhong S, Yang X, Li J, Li Y. Preparation of nanoparticles of β-cyclodextrin-loaded scutellarein anti-tumor activity research by targeting integrin αvβ3. Cancer Nano 2021;12. [DOI: 10.1186/s12645-021-00102-x] [Reference Citation Analysis]